Stay updated on Daratumumab Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial page.

Latest updates to the Daratumumab Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial page
- Check6 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check13 days agoChange DetectedA notice about NIH’s terminology transition appears above the clinical trial record.SummaryDifference0.8%

- Check20 days agoChange DetectedA new study-record version was posted, recording an update to the trial’s study status. The record now shows the study as active but not recruiting.SummaryDifference0.6%

- Check27 days agoChange DetectedThe site’s footer revision label changed from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision entry (v3.7.0) was added to the record history. The previous revision (v3.6.6) was removed from the history.SummaryDifference0.1%

- Check69 days agoChange DetectedThe Record History now includes a new revision tag v3.6.6 and removes the previous v3.6.5 from the history entries.SummaryDifference0.1%

Stay in the know with updates to Daratumumab Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial page.